Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;22(6):901-902.
doi: 10.1007/s40257-021-00642-3. Epub 2021 Oct 27.

Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study

Emma Borg  1 , Henrik Thoning  2
Affiliations
Comment

Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study

Emma Borg et al. Am J Clin Dermatol. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Emma Borg and Henrik Thoning are both employees at LEO Pharma, who market the drug brodalumab, which is one of the assessed drugs in the paper that we comment on.

Comment in

Comment on

References

    1. Torres T, Puig L, Vender R, Lynde C, Piaserico S, Carrascosa JM, et al. Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for psoriasis treatment: a retrospective multi-country, multicentric cohort study. Am J Clin Dermatol. 2021;22(4):567–579. doi: 10.1007/s40257-021-00598-4. - DOI - PubMed
    1. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet. 2002;359(9318):1686–1689. doi: 10.1016/S0140-6736(02)08594-X. - DOI - PubMed
    1. van den Reek J, Kievit W, Gniadecki R, Goeman JJ, Zweegers J, van de Kerkhof PCM, et al. Drug survival studies in dermatology: principles, purposes, and pitfalls. J Invest Dermatol. 2015;135(7):1–5. doi: 10.1038/jid.2015.171. - DOI - PubMed